GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

NCT04917250 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma

Interventions

DRUG: Gemcitabine
DRUG: Pegaspargase
DRUG: Etoposide
DRUG: Dexamethasone

Sponsor

Beijing Tongren Hospital